MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
type: MedicalStudy
description: A Randomized, Triple-Blind, Double-Dummy, Placebo-Controlled, Parallel Groups, Outpatient Study to Examine the Safety and Efficacy of MK0462 10 mg p.o. and MK0462 5 mg p.o. for the Treatment of Acute Migraine and Migraine Recurrence
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 1995-03
end date: 1996-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00897949
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Organon and Co
study subject: Migraine Headache
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Migraine Headache

AI Analytics
type: Organization